Secreted IgM (sIgM) is a multifunctional evolutionary conserved antibody that is critical for the maintenance of tissue homeostasis as well as the development of fully protective humoral responses to pathogens. Constitutive secretion of self‐ and polyreactive natural IgM, produced mainly by B‐1 cells, provides a circulating antibody that engages with autoantigens as well as invading pathogens, removing apoptotic and other cell debris and initiating strong immune responses. Pathogen‐induced IgM production by B‐1 and conventional B‐2 cells strengthens this early, passive layer of IgM‐mediated immune defense and regulates subsequent IgG production. The varied effects of secreted IgM on immune homeostasis and immune defense are facilitated through its binding to numerous different cell types via different receptors. Recent studies identified a novel function for pentameric IgM, namely as a transporter for the effector protein ″apoptosis‐inhibitor of macrophages″ (AIM/CD5L). This review aims to provide a summary of the known functions and effects of sIgM on immune homeostasis and immune defense, and its interaction with its various receptors, and to highlight the many critical immune regulatory functions of this ancient and fascinating immunoglobulin.

MicroRNAs (miRNAs) are highly conserved small non-coding RNA molecules that post-transcriptionally regulate gene expression in multicellular organisms. Within the set of muscle-specific miRNAs, miR-206 expression is largely restricted to skeletal muscle and is found exclusively within the bony fish lineage. Although many studies have implicated miR-206 in muscle maintenance and disease, its role in skeletal muscle development remains largely unknown. Here, we examine the role of miR-206 during Xenopus laevis somitogenesis. In Xenopus laevis, miR-206 expression coincides with the onset of somitogenesis. We show that both knockdown and over-expression of miR-206 result in abnormal somite formation affecting muscle cell rotation, attachment, and elongation. In particular, our data suggests that miR-206 regulates changes in cell adhesion that affect the ability of newly formed somites to adhere to the notochord as well as to the intersomitic boundaries. Additionally, we show that β-dystroglycan and F-actin expression levels are significantly reduced, suggesting that knockdown of miR-206 levels affects cellular mechanics necessary for cell shape changes and attachments that are required for proper muscle formation.

FcμR is present on the cell surface of B cells as well as other antigen presenting cells where they bind the secreted form of IgM (sIgM). Our previous studies have shown that follicular B cells internalize sIgM continuously in vivo and that lack of sIgM or the FcμR on B cells results in diminished IgG responses following influenza virus infection. We aim to determine the mechanisms underlying the need for sIgM in the development of IgG responses. For this we generated HELB-FcmR−/− and HELB-FcmR+/+ mice. In vitro stimulation of purified B cells from these mice with HEL-OVA conjugate in the presence of OVA-specific OTII CD4 T cells showed an antigen-dose-dependent stimulation of both types of B cells. However, FcmR−/− B cells proliferated less at intermediate and low doses of antigen compared to controls, while they proliferated similar as wild type B cells following high-dose antigen stimulation. Intravenous injection of CD45.1-expressing C57BL/6 mice with B cells from either FcmR-deficient or -sufficient CD45.2+ HELB mice together with sheep red blood cells conjugated to HEL showed no significant differences in HEL-specific serum IgM or IgG, or frequencies of HEL-specific B cells between mice receiving either type of B cell, as assessed by ELISA and FACS, respectively. Ongoing studies are aimed at determining whether antigen-dose affects the need for FcmR expression in vivo. For that we have created mixed bone marrow (BM) irradiation chimeras with 2% BM from CD45.2 HELB or HELB-FcmR−/− mice, and 98% CD45.1 wild type BM. To-date our studies suggest that FcmR-IgM interaction enhances B cell proliferation when antigen is limiting. Future studies are aimed at testing this conclusion and explore how sIgM-FcmR interaction enhanced B cell responses.

The FcμR is a cell surface receptor that can bind to both secreted and membrane-bound IgM. In B cells it co-localizes with IgM-BCR in Golgi vesicles, where it restrains surface BCR-IgM expression. B cell-expressed FcmR is required also for maximal IgG response development after influenza A virus infection, but the mechanisms are unknown. To explore the effects of FcmR expression we generated FcmR-deficient and sufficient BCR-”SwHEL” transgenic C57BL/6 mice. The mice, containing about 20% HEL-specific B cells were immunized either directly with hen egg lysozyme (HEL) or with HEL-ovalbumin (OVA), or we created bone marrow irradiation chimeras in which about 2% of naïve B cells expressed the SwHEL-BCR. Consistent with the influenza infection studies, IgG responses following subcutaneous HEL-OVA immunization were significantly diminished in both systems when B cells lacked FcmR−/− expression compared to controls. Confocal and STED microscopy studies on B cells from these mice were done to quantify IgM-BCR internalization following in vitro exposure to HEL-bodipy. FcmR−/− SwHEL B cells did not show IgM “capping” and retained high amounts of antigen on the cell surface compared to the HEL− FcmR+/+ cells. This reduction in internalization resulted in reduced MHCII-peptide loading, as shown via flow cytometric quantification of surface pMHCII expression using the YAE-antibody. Ongoing studies are defining the subcellular compartments of antigen-processing in the presence and absence of the FcmR. We conclude that the FcmR acts as a non-redundant chaperone that optimizes IgM-BCR antigen internalization and processing. U19AI109962 R01AI148652